What is Limbix?
Limbix operates at the intersection of clinical psychology and software development, specializing in the creation of prescription digital therapeutics (PDTs) tailored for adolescent mental health. The company's flagship product, SparkRx, exemplifies its core mission: providing licensed healthcare professionals with validated, technology-enabled tools to treat patients effectively. By integrating the insights of clinicians, researchers, and product designers, Limbix addresses the critical need for scalable, accessible mental health interventions. The company's market position is defined by its adherence to clinical efficacy, distinguishing its platform from general wellness applications and establishing it as a legitimate medical resource within the broader healthcare ecosystem.
How much funding has Limbix raised?
Limbix has raised a total of $24M across 2 funding rounds:
Series A
$9M
Series A
$15M
Series A (2020): $9M with participation from BIXINK Therapeutics, NEXTGEN ANGELS, LLC, Sequoia Capital companies, GSR Ventures, and Storm Ventures Group
Series A (2021): $15M led by GSR Ventures and Digital Garage
Key Investors in Limbix
GSR Ventures
A prominent venture capital firm that focuses on early-stage and growth-stage investments in technology, with a strong emphasis on healthcare, AI, and enterprise software.
Digital Garage
A Japanese technology conglomerate that operates a massive payment platform while actively investing in startups to foster innovation across fintech, digital services, and real estate transformation.
Sequoia Capital
A world-renowned venture capital firm specializing in seed, early, and growth-stage investments, known for backing transformative companies across the technology and healthcare sectors.
What's next for Limbix?
With the support of its latest capital injection, Limbix is poised to accelerate its commercial expansion and deepen its clinical research pipeline. The strategic focus will likely center on broadening the reach of SparkRx while exploring new therapeutic indications that address the complex mental health challenges facing today's youth. As the company scales, it will continue to navigate the regulatory landscape, ensuring that its digital therapeutics maintain the highest levels of safety and efficacy. Future growth will be driven by strategic partnerships with healthcare providers and health systems, further embedding Limbix's solutions into the standard of care for adolescent mental health treatment.
See full Limbix company page
